Latest News

Bota Bio and Medichem Announce Commercial Development Collaboration to Advance Sustainable Pharmaceutical Manufacturing

Bota Bio and Medichem seek to optimize manufacturing processes while committing to environmental sustainability.
Collaboration will leverage Bota Bio’s enzyme engineering expertise to create enzymes that can easily be integrated into Medichem’s conventional chemical processes.

Bota Biosciences

AUG.25.2022

Bota Bio Raises $100 Million As Biology Disrupts The Chemical Industry With Sustainable Manufacturing

The company plans to expand global operations and build a lab-to-pilot scale platform to facilitate the rapid scale-up and deployment of its product pipeline in consumer goods, food, nutrition, and pharmaceutical products.

Forbes

JUL. 29, 2021

Bota Bio Raises $100 Million Series B Financing to Advance Sustainable Bio-manufacturing

Bota Bio, a global industrial biotechnology company advancing sustainable bio-manufacturing, today announced that it has raised more than $100 million in an oversubscribed Series B funding round. The financing was led by Sequoia Capital China. Other investors included previous backers Matrix Partners China, Source Code Capital, Sherpa Healthcare Partners, and 5Y Capital, among others.

Bota Biosciences

JUL. 29, 2021

Bota Bio Ranked as One of the MIT 50 Smartest Companies

MIT Technology Review released the MIT 50 Smartest Companies (TR50) 2020. Bota Biosciences is ranked on the list.

MIT Technology Review

DEC. 20, 2020